BRTX vs. OTRK, MGRX, GBNHF, NURO, GENE, BFRI, MTEM, PRPO, COSM, and VIRI
Should you be buying BioRestorative Therapies stock or one of its competitors? The main competitors of BioRestorative Therapies include Ontrak (OTRK), Mangoceuticals (MGRX), Greenbrook TMS (GBNHF), NeuroMetrix (NURO), Genetic Technologies (GENE), Biofrontera (BFRI), Molecular Templates (MTEM), Precipio (PRPO), Cosmos Health (COSM), and Virios Therapeutics (VIRI). These companies are all part of the "medical" sector.
BioRestorative Therapies (NASDAQ:BRTX) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership.
69.4% of BioRestorative Therapies shares are owned by institutional investors. Comparatively, 13.0% of Ontrak shares are owned by institutional investors. 21.6% of BioRestorative Therapies shares are owned by insiders. Comparatively, 1.2% of Ontrak shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
BioRestorative Therapies has a beta of 61.51, indicating that its share price is 6,051% more volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.5, indicating that its share price is 150% more volatile than the S&P 500.
BioRestorative Therapies has higher earnings, but lower revenue than Ontrak. BioRestorative Therapies is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks.
In the previous week, BioRestorative Therapies had 6 more articles in the media than Ontrak. MarketBeat recorded 8 mentions for BioRestorative Therapies and 2 mentions for Ontrak. Ontrak's average media sentiment score of 1.00 beat BioRestorative Therapies' score of -0.06 indicating that Ontrak is being referred to more favorably in the news media.
Ontrak received 37 more outperform votes than BioRestorative Therapies when rated by MarketBeat users.
Ontrak has a net margin of -219.10% compared to BioRestorative Therapies' net margin of -9,873.97%. BioRestorative Therapies' return on equity of -114.84% beat Ontrak's return on equity.
Ontrak has a consensus target price of $4.00, suggesting a potential upside of 1,408.30%. Given Ontrak's higher possible upside, analysts clearly believe Ontrak is more favorable than BioRestorative Therapies.
Summary
BioRestorative Therapies beats Ontrak on 9 of the 16 factors compared between the two stocks.
Get BioRestorative Therapies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
BioRestorative Therapies Competitors List
Related Companies and Tools
